UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016173 |
|---|---|
| Receipt number | R000018268 |
| Scientific Title | A phase 2 trial of weekly nab-paclitaxel for advanced non-small cell lung cancer without EGFR mutation nor ALK fusion gene in salvage setting |
| Date of disclosure of the study information | 2015/01/15 |
| Last modified on | 2019/03/04 07:43:28 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/01/09 22:59:03 | ||
| 2 | Update | 2015/01/15 09:19:05 | Institutions |
|
| 3 | Update | 2015/02/02 22:21:08 | Recruitment status |
|
| 4 | Update | 2015/07/09 10:10:11 | Institutions |
|
| 5 | Update | 2016/11/06 22:17:44 | Key inclusion criteria |
|
| 6 | Update | 2016/11/06 22:18:29 | Key inclusion criteria |
|
| 7 | Update | 2017/01/10 10:37:04 | Name of primary person or sponsor Organization |
|
| 8 | Update | 2018/03/04 18:01:52 | Institutions |
|
| 9 | Update | 2018/07/17 09:34:18 | Email |
|
| 10 | Update | 2019/02/06 18:36:48 | Recruitment status Last follow-up date |
|
| 11 | Update | 2019/03/04 07:43:28 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
